Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04577963
Title A Study of Fruquintinib in Combination With Tislelizumab in Advanced Triple Negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
Highlands Oncology Springdale Arkansas 72762 United States Details
Beverly Hills Cancer Center Beverly Hills California 90211 United States Details
University of Colorado Aurora Colorado 80045 United States Details
Florida Cancer Specialists - FCS South Port Charlotte Florida 33980 United States Details
Florida Cancer Center North Saint Petersburg Florida 33709 United States Details
Florida Cancer Specialists Panhandle Tallahassee Florida 32308 United States Details
Florida Cancer Specialists - East (FCS East) West Palm Beach Florida 33401 United States Details
HOC AON Baton Rouge / Sarah Cannon Baton Rouge Louisiana 70809 United States Details
Messino Cancer Center Asheville North Carolina 28806 United States Details
Oklahoma University Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Women and Infants Hospital of Rhode Island Providence Rhode Island 02905 United States Details
Tennessee Oncology-Chattanooga Chattanooga Tennessee 37404 United States Details
Tennesse Oncology Nashville Tennessee 37203 United States Details
Vanderbilt Ingram Cancer Center Nashville Tennessee 37232 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field